MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

J&J, Boston Scientific on Hot Seat as Panel Meeting Begins

A crucial meeting of CDRH's Circulatory System Devices Panel is underway, and already representatives from stent companies Johnson & Johnson and Boston Scientific are under fire, reports the Associated Press. The two-day meeting is expected to help FDA and doctors come to a consensus about whether the clotting risks posed by drug-eluting stents outweigh their benefits. Industry says they do not.

Whether the panel believes that will go a long way toward deciding the lucrative products' future commercial prospects in the United States.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.